Tandem Wealth Advisors LLC Has $445,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Tandem Wealth Advisors LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 880 shares of the healthcare conglomerate’s stock after buying an additional 46 shares during the quarter. Tandem Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $445,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $25,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $595.07 on Friday. The firm has a fifty day moving average of $511.79 and a 200-day moving average of $541.87. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $544.32 billion, a price-to-earnings ratio of 38.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.83 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 54.19%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. KeyCorp reiterated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty-one research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $630.35.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.